Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 232 clinical trials in Delft, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)A study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia
The NetherlandsN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
The NetherlandsPhase 1/2 Evaluation of Zilovertamab Vedotin in PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma
The NetherlandsEfficacy and Safety of Subcutaneous Belimumab in Adults with Connective Tissue Disease-Associated Interstitial Lung Disease
The NetherlandsA study of SKB410, enfortumab vedotin, and pembrolizumab combination for patients with locally advanced or metastatic urothelial cancer
The NetherlandsStudy of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment
The NetherlandsA Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease
The NetherlandsA Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones
The NetherlandsA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
The NetherlandsA study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans
The NetherlandsA study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency
The NetherlandsA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on cardiovascular disease management and prevention, including studies of novel treatments for atherosclerotic cardiovascular disease and innovative therapies targeting lipoprotein reduction.
Research exploring both established and experimental treatments to reduce cardiovascular complications and improve patient outcomes.
Comprehensive research into various cancer types, with significant focus on prostate cancer, breast cancer, and blood cancers including chronic lymphocytic leukemia.
Innovative approaches combining established treatments with novel therapeutic agents to enhance treatment effectiveness.
Studies addressing various aspects of women's health, including infertility treatments and management of uterine fibroids.
Research comparing different treatment modalities and their impact on patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
